Focused Ultrasound (s. MRgFUS, transcranial MRI-guided Focused US) Last updated: September 5, 2017
|
|
- Millicent Harrington
- 5 years ago
- Views:
Transcription
1 FOCUSED ULTRASOUND Rx15 (1) Focused Ultrasound (s. MRgFUS, transcranial MRI-guided Focused US) Last updated: September 5, 2017 HISTORY... 1 MODERN ERA... 1 MECHANISMS OF ACTION... 1 HEAT GENERATION... 1 MECHANICAL EFFECTS... 2 BIOEFFECTS AND THEIR ROLE IN NEURO-ONCOLOGY... 2 DIRECT CYTOTOXICITY (TISSUE DESTRUCTION)... 3 INDIRECT CYTOTOXICITY... 3 Radiosensitization... 3 Sonodynamic therapy... 3 Enhanced delivery of therapeutic agents... 3 Immunomodulation... 8 COMPLETED CLINICAL TRIALS... 8 ONGOING CLINICAL TRIALS... 8 BIOEFFECTS AND THEIR ROLE IN FUNCTIONAL NEUROSURGERY... 9 COMPLETED CLINICAL TRIALS... 9 ONGOING CLINICAL TRIALS... 9 BIOEFFECTS AND THEIR ROLE IN VASCULAR NEUROSURGERY... 9 BIOEFFECTS AND THEIR ROLE IN PEDIATRIC NEUROSURGERY STATE OF RESEARCH AND REGULATORY APPROVAL BY DEVELOPMENT STAGE FDA-APPROVED COMMERCIALLY AVAILABLE PLATFORMS PROCEDURAL DETAILS COMPLETED TRIALS ESSENTIAL TREMOR TRIAL CONCLUSIONS ADVANTAGES DISADVANTAGES / CHALLENGES OTHER FACTS HISTORY FUS has been investigated for > 60 years for the potential of applying to cerebral tissue (Fry brothers in the 1950s at University of Illinois along with Iowa neurosurgeon Russell Meyers). clinical use, however, was limited by the need for a craniectomy for acoustic window - intact skull causes beam distortion (defocusing) and energy absorption. at the same time, gamma knife was advanced by Lars Leksell; as a result, FUS for the brain was largely abandoned for several decades. MODERN ERA Three revolutionary technological advances that created new opportunities for FUS: - correction for skull inhomogeneities that defocus the acoustic energy - real-time monitoring 1) phased-array transducers each transducer can be independently controlled ( phase shifted ) to correct for the phase aberrations produced by the variable thickness of the skull. 2) CT technology and algorithms allow for the compensation of irregular skull thickness and density to minimize US deflection and absorption. 3) MR thermometry real-time tissue temperature monitoring safety and confirmation of energy delivery to the target; thus, modern FUS is sometimes called MR-guided FUS (MRgFUS). MECHANISMS OF ACTION Depend on: 1. Intensity (power) of sonication high-intensity (HIFUS) vs. low-intensity (LIFUS) 2. Duration of sonication 3. Mode continuous, pulsed HEAT GENERATION FUS in continuous-wave mode generates frictional energy raises tissue temperature at the focal point - can be monitored with MR thermography. A. LIFUS can generate a low level temperature rise over several minutes or hours (local hyperthermia). B. HIFUS can generate a short (seconds) temperature rise 60ºC that causes protein denaturation (thermal ablation). FUS can create a true lesion in the brain the term noninvasive is inaccurate; the appropriate term incisionless or minimally invasive. lesions can be very sharply delineated with lethal and sublethal effects being separated by only several cell thicknesses. target zone size: from 1x1.5 mm (1/6 of a grain of rice) to 10x16 mm; for larger structures, lesions can be combined (but with cooling period between sonications to prevent unwanted heating of surrounding tissue time-consuming) Tissue effects with temperature and exposure times: As the temperature increases the exposure time needed to achieve thermal tissue destruction decreases exponentially. At 100ºC, tissue boils regardless of the exposure time
2 FOCUSED ULTRASOUND Rx15 (2) (Marie Dauenheimer, year MA, CMI, FAMI) MECHANICAL EFFECTS FUS application in pulsed manner (high power and very short pulses) leads to a low energy deposition in the tissue (minimal thermal rise), however, it creates a large pressure change in the tissue various mechanical effects, from vibration to cavitation. 1. Acoustic cavitation - most prominent mechanical effect of FUS US is a pressure wave consisting of positive (compressive) and negative (rarefactive) components. as US waves propagate through tissue, they interact with dissolved gases. the negative component generates gas-filled microbubbles. as the US exposure continues, the microbubbles continue to oscillate (noninertial or stable cavitation at 0.3 MPa); if the pressure wave amplitude increases to high power (0.9 MPa), the bubbles collapse (inertial cavitation) violent shock waves and high-velocity jets purely mechanical cell disruption or liquefaction (histotripsy). likelihood of cavitation increases as the ultrasound frequency decreases. cavitation microbubbles are easily visible with ultrasound imaging - accurate monitoring. systemic injection of microbubbles lowers the threshold for inertial cavitation at the target - reduced damage to adjacent tissue. cavitation lesions are very precise. Google: US cavitation images (Marie Dauenheimer, year MA, CMI, FAMI) 2. Acoustic radiation forces LIFUS beam momentum transfers to a reflecting or absorbing surface small, steady, unidirectional radiation force along the direction of the beam tissue displacement without destruction can be seen on MRI. 3. Acoustic streaming results from the radiation forces that take place specifically within a liquid medium; resulting circulation may enhance convection. BIOEFFECTS AND THEIR ROLE IN NEURO-ONCOLOGY MRgFUS is a versatile tool!
3 FOCUSED ULTRASOUND Rx15 (3) (Hersh et al. 2016) DIRECT CYTOTOXICITY (TISSUE DESTRUCTION) acoustic cavitation non-thermal ablation (histotripsy) heat generation hyperthermia (> 55ºC) coagulative necrosis thermal ablation 3 ongoing phase I/II clinical trials (NCT , NCT , NCT ) to study thermal ablation of high-grade gliomas or brain metastasis. Exclusion criteria 1. Bleeding diathesis, vascular tumors - to minimize the risk of intracranial hemorrhage. 2. Skull reconstructions, dural patches, clips / implants in the sonication path, cystic areas adjacent to the tumor - to maintain precise control over the energy deposition along the ultrasound beam path. 3. Signs of intracranial hypertension or tumor mass effect - to avoid transient increase in symptomatic cerebral edema. INDIRECT CYTOTOXICITY RADIOSENSITIZATION Heat generation hyperthermia (42ºC) interference with DNA repair, increased blood flow with tumor reoxygenation radiosensitization; o currently, it is technically difficult to administer FUS and radiotherapy simultaneously. o Guthkelch et al (FUS-induced hyperthermia as an adjunct to radiation therapy for the treatment of high grade gliomas) FUS was delivered after craniectomy with temperature monitored via implanted probes difficulties in achieving uniform power deposition highly heterogeneous structure of some tumors, effect of blood flow in vascular tumors. o clinical effect of radiosensitization was demonstrated* with microwave-based hyperthermia but not with FUS-induced hyperthermia. *Sneed et al. 1998: Hyperthermia was associated with significantly longer time to progression (P = 0.045) and survival (P = 0.02). Median survival was 76 weeks vs 85 weeks and 2-year survival was 15% vs 31% for the control vs hyperthermia groups, respectively. SONODYNAMIC THERAPY Cavitation / heat generation activation of sonosensitizers, generation of reactive oxygen species (free radicals, singlet oxygen) cellular damage (sonodynamic therapy) o it is a noninvasive alternative to photodynamic therapy (light has poor tissue penetration requiring implantable interstitial fiberoptic sources). o sonodynamic therapy mechanism in brain is demonstrated in animal studies only; however, hematoporphyrin monomethyl ether, protoporphyrin IX, and ATX-70 have been shown to have sonodynamic effects in sarcoma, hepatocellular carcinoma, osteosarcoma, and endometrial cancer Effect of sonodynamic therapy with 5-ALA and FUS for intracranial glioma in rat: (Ohmura et al. 2011) ENHANCED DELIVERY OF THERAPEUTIC AGENTS a) acoustic pressure change at a precise location endothelium releases nitric oxide vasodilation increased amount of drug delivered to the target). b) drug is encapsulated in / bonded to a carrier vehicle (e.g. microbubble, liposome, nanoparticle), that is sensitive to either elevated temperatures or pressures* carrier vehicles are injected systemically drug is only released in the area targeted by FUS (targeted drug release). *e.g. low temperature sensitive liposomes (LTSLs), acoustic pressure-sensitive carriers.
4 FOCUSED ULTRASOUND Rx15 (4) (Marie Dauenheimer, year MA, CMI, FAMI) c) IV administration of US contrast agents (microbubbles that concentrate by the capillary walls) pulsed LIFUS (low pressure, low frequency 500 khz) formation of cavitation bubbles disruption of tight intercellular junctions in endothelium transient selective opening the bloodbrain barrier (happens immediately, may endure up to 4-6 hours with reversal to its original structure without permanent damage) N.B. although the BBB is disrupted in many gliomas, it often remains intact at the periphery of the tumor, where invading tumor cells are interspersed with healthy brain cells. Normal BBB is impermeable to molecules > 400 Da; disrupted BBB allows delivery of molecules as big as antibodies. (Marie Dauenheimer, year MA, CMI, FAMI) Microbubble size effect 4-5 micron bubbles better match brain capillary diameter (4-10 µ) with better BBB opening
5 FOCUSED ULTRASOUND Rx15 (5) Microbubble size and US acoustic pressure effect (e.g. 1-2 µ microbubbles with 0.3 MPa do not open BBB): BBB opening with smaller microbubbles and less acoustic pressures lasts shorter: (Sun et al. 2013) Larger acoustic pressures make BBB openings larger larger molecules can penetrate BBB to the larger area: (Chen et. al. 2014) Fluorescein-dextran (70 kda) penetration into mouse hippocampus (higher magnification shows that uptake is into actual neurons):
6 FOCUSED ULTRASOUND Rx15 (6) Fluorescent BDNF (brain-derived neurotrophic factor) delivery under sonication: (Choi et al. 2011) (Baseri et al. 2012) BBB opening is larger in awake state vs. sedated (anesthesia) state in nonhuman primate brain (mechanism unknown): (Konofagou 2015) o BBB closure time is independent of the volume of BBB opened (O'Reilly MA et al. 2017) important for safety opening BBB in large areas. o ongoing phase I trial (NCT ) in patients with GBM who are being treated with doxorubicin; the first patient was treated, and the BBB was successfully opened (confirmed with contrast enhancement on the postsonication MRI). SonoCloud device (CarThera) - 1 MHz ultrasound implant for BBB opening; does not need MRI for thermography:
7 FOCUSED ULTRASOUND Rx15 (7) d) acoustic radiation and acoustic streaming tissue shear and displacement, fluid circulation US-assisted enhanced local drug delivery (distribution through the extracellular space, penetration of tissue-tumor barrier). o mechanism demonstrated in preclinical studies only. o possible to combine with brain-penetrating nanoparticles with a dense poly(ethylene glycol) coating that prevents nonspecific binding to components of the brain extracellular matrix. Distribution of catheter infused Evans blue dye by convection-enhanced delivery (CED) without and with unfocused ultrasound exposure: (Lewis et al. 2011) e) stable cavitation pores in cell membranes permeability of cell membranes (sonoporation) enhanced drug absorption into cells intracellular drug trapping after termination of sonoporation
8 FOCUSED ULTRASOUND Rx15 (8) (Marie Dauenheimer, year MA, CMI, FAMI) IMMUNOMODULATION Immunomodulation of the tumor microenvironment. o thermal < mechanical effects tumor cellular debris presentation of tumor-specific antigens, changes in chaperone expression, and cytokine secretion enhanced immune recognition and tumor clearance o mechanism demonstrated in preclinical and clinical studies but clinical outcome studies are lacking. o added benefit: FUS tumor ablation causes amplified release of cellular debris with tumor biomarkers into systemic circulation potential for diagnostics. (Marie Dauenheimer, year MA, CMI, FAMI) COMPLETED CLINICAL TRIALS New / recurrent glioma or metastatic brain tumors when conventional surgery is not an option: NCT (University Children's Hospital Switzerland) - MR-guided Focused Ultrasound in the Treatment of Brain Tumors No study results posted yet ONGOING CLINICAL TRIALS Recurrent metastatic brain tumors: NCT (Brigham & Women's Hospital, Swedish Medical Center) - FUS Feasibility Study for Brain Tumors, Phase 1 trial Glioma, Metastatic Brain Cancer: NCT (Sunnybrook Health Sciences Centre, Canada) - ExAblate FUS Treatment of Brain Tumors Safety of BBB disruption using transcranial MRI-guided focused ultrasound in conjunction with a contrast agent to increase doxorubicin in brain tumors NCT (Sunnybrook Health Sciences Centre, Canada)
9 FOCUSED ULTRASOUND Rx15 (9) BIOEFFECTS AND THEIR ROLE IN FUNCTIONAL NEUROSURGERY 1. Thermal ablation Women s Medical University in Tokyo Nov 2016 first hand dystonia patient treated with FUS to target ventrooralis (Vo) nucleus of the thalamus 35-yo guitar player (MRI-compatible guitar): 2. BBB disruption (e.g. for delivery of anti A-beta antibodies to decrease amyloid burden in Alzheimer s disease demonstrated in animal studies with improvement in functional performance along with increased neurogenesis). 3. Neuromodulation exact mechanism unknown but likely by mechanical effects; depending on parameters chosen, FUS can reversibly: a) inhibit neurons test lesion prior to therapeutic FUS (i.e. clinical target confirmation) b) stimulate neurons* brain mapping with high precision *mechanism of this action may be through the mechanical alteration of voltagesensitive ion channels or by causing bursts of action potentials by causing changes in neuronal cell membrane permeability Lee at al. group (2016) induced phosphenes by FUS stimulation of V1 accompanied by EEG and fmri changes in that area 4. FUS induces release of chemoattractant molecules, expression of cellular adhesion molecules on endothelial cells stem cell homing (demonstrated in preclinical studies) - targeting stem cell delivery for neurodegenerative diseases. 5. Remyelination in MS - completed preclinical in vivo pilot study at the University of Washington in Seattle (Mourad et al. 2017) pulsed FUS (only one side of the brain for 30 minutes every day for 5 days) increased corpus callosum myelination by 5% (relative to untreated side) in 6 out of 7 animals. COMPLETED CLINICAL TRIALS Essential tremor: NCT (UVA) - ExAblate FUS in the Treatment of Essential Tremor ONGOING CLINICAL TRIALS Parkinson disease: 1) NCT (UVA, Swedish Medical Center) - ExAblate FUS for Parkinson's Disease 2) NCT (UVA) - ExAblate FUS of STN for Parkinson's Disease 3) NCT (UVA, Univ of Maryland, Ohio State Wexner Medical Center) - ExAblate FUS of GPi for Parkinson's Disease Epilepsy: 1) NCT (UCLA) - LIFUS Pulsation for Temporal Lobe Epilepsy; Device: BrainSonix Inc. 2) NCT (UVA) - ExAblate thermal ablation of a subcortical focal epileptic targets. OCD: NCT (Yonsei University, Korea) - ExAblate FUS for Medication Refractory Obsessive Compulsive Disorder Depression: NCT (Yonsei University, Korea) - ExAblate FUS for Bilateral Anterior Capsulotomy (anterior limb of internal capsule) for Medication-Refractory MDD Neuropathic pain: NCT (University Children's Hospital, Switzerland) FUS Thalamotomy for Neuropathic Pain Disorders of consciousness: NCT (UCLA) - Thalamic LIFUS in Acute Brain Injury BIOEFFECTS AND THEIR ROLE IN VASCULAR NEUROSURGERY Inertial cavitation mechanical clot disruption (sonothrombolysis); enhanced by microbubbles and/or thrombolytic agents - potential noninvasive treatment for intracranial hemorrhage - potential noninvasive augmentation of tpa effects in stroke - T2 MRI is the optimal imaging for successful sonothrombolysis - thrombus becomes brighter (like serum). Human cadaver. M1 clot was induced by injecting thrombin through endovascular microcatheter and flow was maintained by saline pumping system. FUS targeted M1 clot (arrows), and with total of four sonications, clot was completely sonothrombolyzed over 10 minutes:
10 FOCUSED ULTRASOUND Rx15 (10) (Ghanouni et al. 2015) BIOEFFECTS AND THEIR ROLE IN PEDIATRIC NEUROSURGERY children have thinner skulls (difficult stereotactic frame pinning) but, neonates in particular, possess a natural acoustic window through their fontanelle. neonates require MR-compatible incubators and dedicated neuro-interventional coils for imaging. J. Drake et al. group (Canada) developed HIFU for Pediatric Operations (HOPE) a pediatric neurosurgical treatment system for: 1) focal brain ablation/disconnection for medical refractory epilepsy 2) lysis of intra-ventricular hemorrhage. HOPE system integrates MR-compatible robot positioning device (positions the US transducer to an accuracy of / mm) and imaging coil integrated into the incubator. (Drake et al. 2016) STATE OF RESEARCH AND REGULATORY APPROVAL BY DEVELOPMENT STAGE
11 FOCUSED ULTRASOUND Rx15 (11) (FUS foundation, March 2017) FUS is not approved by any regulatory bodies worldwide as a treatment for brain tumors! November 15, 2016: Centers for Medicare and Medicaid Services (CMS) has set the institutional payment for FUS treatment for essential tremor at approximately $10,000. after 2 years CMS will reevaluate the payment level based on the actual costs of treatments performed during that interval. FDA-APPROVED COMMERCIALLY AVAILABLE PLATFORMS Sonablate (SonaCare Medical, Charlotte, NC) FDA-approved in 2015 for ablation of prostate tissue (BPH, prostate cancer) Ablatherm (EDAP TMS S.A., France) FDA-approved in 2015 for ablation of prostate tissue (BPH, prostate cancer) ExAblate Neuro (InSightec LTD, Israel) FDA-approved for bone metastasis and uterine fibroids; FDA-approved for essential tremor in July 2016 (cf. DBS for essential tremor was FDA approved in 1997). approved in Europe and Korea also for the Parkinsonian tremor, neuropathic pain, depression, obsessive-compulsive disorder, osteoid osteoma. hemispheric, 650 khz, 1024 element, phased-array transducer that is coupled to 3T MRI: PROCEDURAL DETAILS head is shaved patient is placed in a stereotactic frame that is coupled to MRI-compatible FUS transducer. elastic barrier is placed over the frame that is filled with chilled, degassed water in order to prevent excessive scalp heating and minimize acoustic scatter: anatomical MRI scans fusion with preoperative CT (to allow for correction of skull thickness and density) planning of stereotactic target:
12 FOCUSED ULTRASOUND Rx15 (12) treatment planning images are also used to delineate a safe sonication pathway using: CT - to mark intracranial calcifications in the choroid plexus, falx cerebri, basal ganglia, or vessels; MR - to demarcate no-pass regions around the sinuses and any air trapped between the elastic membrane and the scalp (because of the risk of ultrasound absorption and heating in these locations). fiducial markers are placed on the images along the ventricular and cortical margins to aid in movement detection. treatment plan is assessed to confirm that at least 700 elements of the transducer are active and that the skull area to be sonicated is at least 250 cm 2, allowing adequate distribution of ultrasound energy over the skull. acoustic low-level energy is administered with incremental increases to reach target temperature C each brief sonication is monitored with MR thermometry, and the awake patient is clinically assessed for tremor reduction and adverse effects (tissue stunning effect lasts few minutes after turning US off enough time to test patient): once target is confirmed, acoustic energy is sequentially titrated to therapeutic range (60 C) for tissue ablation (energy required is 10,000-20,000 Joules) while monitoring heat map: 90% of this acoustic energy is reflected or absorbed by the skull (skull has the potential to heat significantly) tremor suppression is usually first noted at 50 C (stunned brain target) Cardioversion uses only Joules! predictable changes in MRI (T2 and T1) on POD1: MRI features after MRg-FUS ablation of left VIM. FUS lesion (arrows) appears on T2-weighted images at 24 hours and initially restricts diffusion. It shows faint enhancement at 1 month, and cavity collapses by 3 months. Blood product staining is seen immediately after MRI-guided FUS treatment and persists over time:
13 FOCUSED ULTRASOUND Rx15 (13) (Ghanouni et al. 2015) T2: Zones 1 and 2 represent coagulation necrosis and cytotoxic edema; the poorly marginated slightly T2 hyperintense zone 3 at the periphery represents vasogenic edema. Zone 3 is typically seen between 24 hours and 1 week and then resolves. Zones 1 and 2 evolve into a round or oval cavity at 1 week and 1 month and collapse by 3 months. Small amounts of blood products, but no frank hemorrhage, are seen at the target site immediately after the MRI-guided FUS treatment and afterward. A few patients displayed very mild and transient enhancement at the target site at 24 hours, likely resulting from the reversible alteration of the BBB caused by the MRI-guided FUS treatment. Enhancement reappeared by 1 week and peaked at 1 month, possibly related to neovascularization. ESSENTIAL TREMOR TRIAL COMPLETED TRIALS International, multicenter, prospective, randomized, double-blinded, sham-controlled trial ClinicalTrials.gov number: NCT Sites: 1) University of Virginia 2) Toronto Western Hospital 3) Sunnybrook Health Sciences Centre (Toronto) 4) Methodist Neurological Institute (Houston) 5) Stanford University 6) Swedish Neuroscience Institute (Seattle) 7) University of Maryland 8) University of Miami 9) Brigham and Women s Hospital 10) Yonsei University (South Korea) 11) Shin-yurigaoka General Hospital (Japan) 12) Tokyo Women s Medical University (Japan) Trial design 76 patients with moderate-to-severe, medication-refractory* essential tremor. *failed at least two trials of medical therapy. skull density ratio (ratio of cortical to cancellous bone on CT) of patients were blinded and randomly assigned in a 3:1 ratio to undergo: a) unilateral FUS thalamotomy with ExAblate Neuro (InSightec) b) sham procedure. there were no significant differences in baseline characteristics between the two study groups:
14 FOCUSED ULTRASOUND Rx15 (14) only the treatment team was aware of the group assignments. tremor assessments by blinded neurologists - at baseline, at 1, 3, 6, and 12 months postop. 32-point tremor scale (higher scores = more severe tremor). primary outcome - the between-group difference in the change from baseline to 3 months in contralateral hand tremor. open-label extension cohort: after 3 months, patients in the sham-procedure group could cross over to active treatment group. RESULTS hand-tremor scores improved: FUS group: (delta 8.5 = 47% improvement) sham group: (delta 0.2 = 0.1% improvement) between-group difference: 8.3 points ( CI 95%; P < 0.001). Individual tremor responses at 3 months: improvement in the FUS group was still maintained at 12 months (change from baseline, 7.2 points = 40% improvement). Compare to pilot trial - mean tremor reduction of 75% at 1 year Tremor scores at baseline and throughout the 12-month study period: cross-over group had tremor improvement by 55% at 3 months and by 52% at 6 months secondary outcome also improved with FUS treatment: disability 62% vs. 3% reduction (P < 0.001) quality of life 46% vs. 3% reduction (P < 0.001) 30% of patients in FUS group (vs. 0% in sham group) reported heat or pressure inside the head during procedure (resolved within seconds postop). in 5 patients, the full therapeutic temperature could not be achieved, despite adequate acoustic energy (probably due to individual cranial characteristics). the stereotactic target had to be adjusted (based on intraoperative clinical or imaging feedback) by 1.6±1.1 mm (range, 1.1 to 5.5) in 39 patients. adverse events in FUS group:
15 FOCUSED ULTRASOUND Rx15 (15) 1) gait disturbance - 36% patients (9% at 12 months) 2) paresthesias or numbness - 38% patients (14% at 12 months) 3) contralateral weakness (internal capsule effect) - 4% patients (2% at 12 months) 4) no infectious or hemorrhagic events 5) the intensity of side effects seemed to peak at approximately 1 week, corresponding to the maximal size of the lesion with perilesional edema. Conclusions - thalamotomy significantly (nearly 50%) reduced hand tremor at 3 months, and the effect (40% improvement) persisted during the 12-month study period these are results for advanced, medically-refractory ET and yet results are better than medical management at early disease stages. - tremor reduction was related to treatment, not a placebo effect. - FUS lesioning can result in permanent neurological deficits. ADVANTAGES CONCLUSIONS FUS can noninvasively transmit high-intensity acoustic energy with a high degree of accuracy, precision, and safety to the targets within the skull. FUS offers exciting options for the incisionless treatment of numerous neurological disorders through numerous mechanisms as either a stand-alone or (neo)adjuvant treatment modality: 1) ablative applications of FUS in the brain are already implemented clinically. 2) sonodynamic therapy, radiosensitization, drug delivery, and immunomodulation have been more extensively explored in other organ systems than in brain. the closest competitor is SRS; FUS advantages over SRS: 1) SRS dose gradient is less sharp 2) SRS does not allow intraoperative target validation (neither clinical nor imaging) 3) SRS effects are delayed 4) SRS carries risks of radiation side effects there are preliminary works of combining SRS and FUS for tumor treatment (Schlesinger et al. 2017) - FUS may be used to debulk the main tumor mass, and radiation to treat the surrounding tumor bed. DISADVANTAGES / CHALLENGES FUS is not a walking in the park type of the procedure patient needs to spend 3-4 hours inside the MRI scanner bore with the shaved head immobilized in pins. FUS is able to create true intracranial lesions with the attendant risks of permanent adverse effects, so FUS cannot be called noninvasive. due to limitations of current technology, FUS cannot be applied to posterior fossa, skull base, and cortical areas. currently in the U.S., FUS is most commonly used for the ablation of uterine fibroids and prostate cancer; therefore, the postmarketing experience for neurological applications is still in the early stages. treatment of tumors (vs. functional applications) is challenging: tumor location may be anywhere in the brain, tumors tend to be more vascular and made of nonhomogeneous tissue, and it may require a large treatment volumes; possible solution - low frequency FUS to increase treatment envelope (but also higher risk of cavitation injury) khz ExAblate Neuro system with a real-time cavitation monitoring system is in development
16 FOCUSED ULTRASOUND Rx15 (16) OTHER FACTS The InSightec system is approximately $2mil-this would be for the transducer that we would use for movement disorders (target area is 20-30mm around AC/PC). There is another transducer currently under development that will be able to go more laterally and create larger lesions. Tres Glenn Customer Executive-East Zone, Americas M: us.insightec.com BIBLIOGRAPHY 1. FUS foundation: 2. FUS foundation: An Overview of the Biological Effects of Focused Ultrasound (July 2015) 3. Bond (2016) - Randomized, Sham-Controlled Trial of Transcranial Magnetic Resonance-Guided FUS Thalamotomy 4. Elias (2016) - A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor 5. FUS foundation: Focused Ultrasound for Glioblastoma Workshop 6. Ghanouni (2015) - Transcranial MRI-Guided Focused Ultrasound - A Review of the Technologic and Neurologic Applications 7. Hersch (2016) - Emerging Applications of Therapeutic Ultrasound in Neuro-oncology 8. Weintraub (2016) - The emerging role of transcranial magnetic resonance imaging-guided focused ultrasound in functional neurosurgery 9. Wu (2017) - Pulsed-wave low-dose ultrasound hyperthermia selectively enhances nanodrug delivery...to brain mts
17 FOCUSED ULTRASOUND Rx15 (17) Viktor s Notes for the Neurosurgery Resident Please visit website at
Non-invasive Neurosurgery using MR guided Focused Ultrasound
Non-invasive Neurosurgery using MR guided Focused Ultrasound About InSightec Founded in 1999, headquarters Haifa, Israel US offices in Dallas, Texas Asian offices in Beijing, China, and Tokyo, Japan Develop
More informationNeurosurgery. MR GUIDED FOCUSED ULTRASOUND (MRgFUS) Non-invasive thalamotomy for movement disorders & pain
Neurosurgery MR GUIDED FOCUSED ULTRASOUND (MRgFUS) Non-invasive thalamotomy for movement disorders & pain INSIGHTEC NEURO - NEXT GENERATION NEUROSURGERY INSIGHTEC the global leader in Magnetic Resonance
More informationMRg HIFU: Current and future trends of MR guided Focused Ultrasound in Radiation Oncology. Arik Hananel MD, MBA, BsCs
MRg HIFU: Current and future trends of MR guided Focused Ultrasound in Radiation Oncology Arik Hananel MD, MBA, BsCs Disclosure InSightec http://www.insightec.com Focused Ultrasound Foundation http://www.fusfoundation.org
More information2/11/2009. Evidence for the Molecular, Cellular and Physiological Effects of Microstreaming and Cavitation at MHz and khz Ultrasound Frequencies
Evidence for the Molecular, Cellular and Physiological Effects of Microstreaming and Cavitation at MHz and khz Ultrasound Frequencies ISEPA : Las Vegas : Feb 2009 Professor Tim Watson University of Hertfordshire
More informationImagine your tremor free life! Non-Invasive Treatment for Essential Tremor
Imagine your tremor free life! Non-Invasive Treatment for Essential Tremor The non-invasive treatment for Essential Tremor (ET) is performed using Neuravive. WHAT IS ESSENTIAL TREMOR? Essential Tremor
More information1. POLICY: Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for Essential Tremor
Retired Date: Page 1 of 10 1. POLICY: Magnetic Resonance Image (MRgFUS) for Essential Tremor 2. RESPONSIBLE PARTIES: Medical Management Administration, Utilization Management, Integrated Care Management,
More informationUNPRECEDENTED BENEFITS TRANSFORMATIVE RESULTS. In clinical studies, patients reported an immediate, significant reduction of tremor.
UNPRECEDENTED BENEFITS TREMOR IMPROVEMENT In clinical studies, patients reported an immediate, significant reduction of tremor. * NON-INVASIVE Focused ultrasound is capable of penetrating the skull without
More informationFocused ultrasound (FUS) thalamotomy was recently. FOCUS Neurosurg Focus 44 (2):E5, 2018
NEUROSURGICAL FOCUS Neurosurg Focus 44 (2):E5, 2018 Predicting lesion size during focused ultrasound thalamotomy: a review of 63 lesions over 3 clinical trials Aaron E. Bond, MD, PhD, and W. Jeffrey Elias,
More informationBrain Applications of Focused Ultrasound. Neal F. Kassell, M.D. Jessica Foley, PhD John Snell, PhD
Brain Applications of Focused Ultrasound Neal F. Kassell, M.D. Jessica Foley, PhD John Snell, PhD History of Ultrasound 1800 Piezoelectric effect: Pierre & Marie Curie 1881 Converse Effect: Gabriel Lippmann
More informationPACEMAKERS ARE NOT JUST FOR THE HEART! Ab Siadati MD
PACEMAKERS ARE NOT JUST FOR THE HEART! Ab Siadati MD WHAT IS DEEP BRAIN STIMULATION? WHY SHOULD YOU CONSIDER DBS SURGERY FOR YOUR PATIENTS? HOW DOES DBS WORK? DBS electrical stimulation overrides abnormal
More informationSurgical Treatment for Movement Disorders
Surgical Treatment for Movement Disorders Seth F Oliveria, MD PhD The Oregon Clinic Neurosurgery Director of Functional Neurosurgery: Providence Brain and Spine Institute Portland, OR Providence St Vincent
More informationThe Yesterday, Today and Tomorrow of Focused Ultrasound Surgery CHONGQING HAIFU (HIFU) TECHNOLOGY CO., LTD.
The Yesterday, Today and Tomorrow of Focused Ultrasound Surgery 1 Terms and Principle Evolution of surgery in the last 200 years Open Surgery Laparoscopic Surgery Focused Ultrasound Surgery 2 Terms and
More informationProtocol. This trial protocol has been provided by the authors to give readers additional information about their work.
Protocol This trial protocol has been provided by the authors to give readers additional information about their work. Protocol for: Elias WJ, Huss D, Voss T, et al. A pilot study of focused ultrasound
More informationSYSTEM OVERVIEW MINIMALLY INVASIVE ROBOTIC LASER THERMOTHERAPY
SYSTEM OVERVIEW MINIMALLY INVASIVE ROBOTIC LASER THERMOTHERAPY Software NeuroBlate Fusion Software is the exclusive software intelligence behind the NeuroBlate System. NeuroBlate Fusion allows neurosurgeons
More informationSurgical Treatment: Patient Edition
Parkinson s Disease Clinic and Research Center University of California, San Francisco 505 Parnassus Ave., Rm. 795-M, Box 0114 San Francisco, CA 94143-0114 (415) 476-9276 http://pdcenter.neurology.ucsf.edu
More informationHigh-Intensity Focused Ultrasound Therapy - an Overview and principles about a new weapon in cancer therapy
High-Intensity Focused Ultrasound Therapy - an Overview and principles about a new weapon in cancer therapy High-intensity focused ultrasound therapy is a novel, emerging, therapeutic modality that uses
More informationChina Medical Technologies, Inc.
China Medical Technologies, Inc. China Medical Technologies, Inc. (CMT) is a high-tech enterprise, trading on Nasdaq with the ticker CMED. We currently conduct our operations principally through our wholly-owned
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Elias WJ, Lipsman N, Ondo WG, et al. A randomized trial of
More informationProceedings of Meetings on Acoustics
Proceedings of Meetings on Acoustics Volume 19, 2013 http://acousticalsociety.org/ ICA 2013 Montreal Montreal, Canada 2-7 June 2013 Biomedical Acoustics Session 1pBAb: Ultrasound Contrast Agents and Passive
More informationUltra High-Field MRI as a Therapeutic Modality for the Treatment of Brain Metastases with Comparison to MR Guided Focused Ultrasound
Ultra High-Field MRI as a Therapeutic Modality for the Treatment of Brain Metastases with Comparison to MR Guided Focused Ultrasound Joshua de Bever, PhD Department of Radiology Stanford University STANFORD
More informationCLINICAL MEDICAL POLICY
Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICAL POLICY Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) MP-094-MD-DE Medical Management Provider Notice Date: 04/01/2019 Issue
More informationSurgical Options. A History of Surgical Treatment. Patient selection. Essential Tremor (ET)
Essential tremor (ET) is the most common movement disorder, impacting the lives of an estimated 10 million Americans and millions more worldwide. At this time, there is no cure for ET and only about 50%
More informationExpanding therapy options for
MR systems Sonalleve MR-HIFU Expanding therapy options for women s health and oncology 2 Discover the freedom of patient-friendly and non-invasive therapy options Sonalleve MR-HIFU is an innovative therapy
More informationMR Guided Focused Ultrasound Treatment for Essen7al Tremor
MR Guided Focused Ultrasound Treatment for Essen7al Tremor Paul S. Fishman MD, PhD Professor of Neurology University of Maryland School of Medicine Chief of Neurology VA Maryland Health Care System Brain
More informationJournée industrielle PRIMES, 12 juin Nicolas Guillen, EDAP TMS France
Multi modality imaging for prostate cancer targeting and treatment Journée industrielle PRIMES, 12 juin 2014 Nicolas Guillen, EDAP TMS France Focal One device Focal One is the first device dedicated to
More informationStereotactic Radiosurgery. Extracranial Stereotactic Radiosurgery. Linear accelerators. Basic technique. Indications of SRS
Stereotactic Radiosurgery Extracranial Stereotactic Radiosurgery Annette Quinn, MSN, RN Program Manager, University of Pittsburgh Medical Center Using stereotactic techniques, give a lethal dose of ionizing
More informationModeling of Thermal Damage from Focused Ultrasound Exposures for Heterogeneous Tissues
Modeling of Thermal Damage from Focused Ultrasound Exposures for Heterogeneous Tissues Adam C. Waspe, PhD adam.waspe@sickkids.ca Aug. 11, 2014 * Some content adapted from lecture notes from Rajiv Chopra
More informationDBS Programming. Paul S Fishman MD, PhD University of Maryland School of Medicine PFNCA 3/24/18
DBS Programming Paul S Fishman MD, PhD University of Maryland School of Medicine PFNCA 3/24/18 Disclosure The University of Maryland has received research funding form InSightec and the Focused Ultrasound
More informationRobotic HIFU intervention under US guidance
Focused Ultrasound Therapy Using Robotic Approaches FUTURA project Project ID: 611963 Objective: ICT-2013.2.1 Robotics, Cognitive Systems & Smart Spaces, Symbiotic Interaction WORKSHOP ON: Interventions
More informationNOW WITH SYSTEM OVERVIEW MINIMALLY INVASIVE ROBOTIC LASER THERMOTHERAPY
NOW WITH SYSTEM OVERVIEW MINIMALLY INVASIVE ROBOTIC LASER THERMOTHERAPY Mini-Bolt Access Robotically Controlled Probe Driver MRI-Guided Laser Energy PRECISION AND CONFIDENCE DELIVERED THROUGH A MINIMALLY
More informationDeep Brain Stimulation for Parkinson s Disease & Essential Tremor
Deep Brain Stimulation for Parkinson s Disease & Essential Tremor Albert Fenoy, MD Assistant Professor University of Texas at Houston, Health Science Center Current US Approvals Essential Tremor and Parkinsonian
More informationClinical Commissioning Policy Proposition:
Clinical Commissioning Policy Proposition: Stereotactic Radiosurgery (SRS) for adults with Parkinson's tremor and Familial Essential Tremor Version Number: NHS England B13X06/01 Information Reader Box
More informationBuilding a Stroke Portfolio. June 28, 2018
Building a Stroke Portfolio June 28, 2018 1 Forward-Looking Statements This presentation contains forward-looking statements, including statements relating to: the potential benefits, safety and efficacy
More informationNoninvasive Blood-Brain Barrier Opening in Live Mice
Noninvasive Blood-Brain Barrier Opening in Live Mice James J. Choi 1, Mathieu Pernot 1, Scott Small 3, and Elisa E. Konofagou 1,2 1 Department of Biomedical Engineering, 2 Department of Radiology, 3 Department
More informationSee Policy CPT/HCPCS CODE section below for any prior authorization requirements
Effective Date: 1/1/2019 Section: SUR Policy No: 395 1/1/19 Medical Policy Committee Approved Date: 8/17; 2/18; 12/18 Medical Officer Date APPLIES TO: Medicare Only See Policy CPT/HCPCS CODE section below
More informationFocused ultrasound (FUS) offers a minimally invasive
CLINICAL ARTICLE Skull bone marrow injury caused by MR-guided focused ultrasound for cerebral functional procedures Michael L. Schwartz, MD, MSc, 1,2 Robert Yeung, MD, 2,3 Yuexi Huang, PhD, 4 Nir Lipsman,
More informationThe Surgical Management of Essential Tremor
The Surgical Management of Essential Tremor International Essential Tremor Foundation Learning About Essential Tremor: Diagnosis and Treatment Options Albuquerque, NM September 24, 2005 Neurosurgeon Overview:
More informationModeling of the Impact of Blood Vessel Flow on the Temperature Distribution during Focused Ultrasound Treatments
Presented at the COMSOL Conference 2010 Boston Modeling of the Impact of Blood Vessel Flow on the Temperature Distribution during Focused Ultrasound Treatments Elisabetta Sassaroli, King C. P. Li, Brian
More information10ème Congrès Français d'acoustique Lyon, Avril 2010
1ème Congrès Français d'acoustique Lyon, 12-16 Avril 21 Stabilization of Cavitation Zone for Therapeutic Applications A. Moussatov, C. Lafon, J.-L. Mestas, S. Chesnais, J. Ngo, L. Somaglino, J.-Y. Chapelon
More informationNumerical Study of a Simple Transcranial Focused Ultrasound System Applied to Blood-Brain Barrier Opening
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, vol. 57, no. 12, December 2010 2637 Numerical Study of a Simple Transcranial Focused Ultrasound System Applied to Blood-Brain Barrier
More informationEMERGING TREATMENTS FOR PARKINSON S DISEASE
EMERGING TREATMENTS FOR PARKINSON S DISEASE Katerina Markopoulou, MD, PhD Director Neurodegenerative Diseases Program Department of Neurology NorthShore University HealthSystem Clinical Assistant Professor
More informationIntracranial Studies Of Human Epilepsy In A Surgical Setting
Intracranial Studies Of Human Epilepsy In A Surgical Setting Department of Neurology David Geffen School of Medicine at UCLA Presentation Goals Epilepsy and seizures Basics of the electroencephalogram
More informationPublic Presentation 2014, NOVEMBER
Focused Ultrasound Therapy Using Robotic Approaches Public Presentation 2014, NOVEMBER Project ID: 611963 Objective: ICT-2013.2.1 Robotics, Cognitive Systems & Smart Spaces, Symbiotic Interaction PROJECT
More informationESCRIPTION OF PROCEDURE/SERVICE/PHARMACEUTICAL
Subject: Magnetic Resonance Guided Focused Ultrasound (MRgFUS) for Essential Tremor Original Effective Date: 7/10/18 Policy Number: MCP-312 Revision Date(s): Review Date: MCPC Approval Date: 7/10/18 DISCLAIMER
More informationSURGICAL MANAGEMENT OF BRAIN TUMORS
SURGICAL MANAGEMENT OF BRAIN TUMORS LIGIA TATARANU, MD, Ph D NEUROSURGICAL CLINIC, BAGDASAR ARSENI CLINICAL HOSPITAL BUCHAREST, ROMANIA SURGICAL INDICATIONS CONFIRMING HISTOLOGIC DIAGNOSIS REDUCING TUMOR
More informationResearch Perspectives in Clinical Neurophysiology
Research Perspectives in Clinical Neurophysiology A position paper of the EC-IFCN (European Chapter of the International Federation of Clinical Neurophysiology) representing ~ 8000 Clinical Neurophysiologists
More informationResearch Article MRI Guided Focused Ultrasound Thalamotomy for Moderate-to-Severe Tremor in Parkinson s Disease
Parkinson s Disease Volume 2015, Article ID 219149, 4 pages http://dx.doi.org/10.1155/2015/219149 Research Article MRI Guided Focused Ultrasound Thalamotomy for Moderate-to-Severe Tremor in Parkinson s
More informationON CELLS AND SOUND. Kingston upon Hull HU6 7RX, United Kingdom. University of Orléans, rue Charles Sadron, Orléans Cedex 2, France
Spiros Kotopoulis, Anthony Delalande, Chantal Pichon and Michiel Postema. On Cells and Sound Proceedings of the 34 th Scandinavian Symposium on Physical Acoustics, Geilo 30 January 2 February, 2011. ON
More informationBrain Tumor Treatment
Scan for mobile link. Brain Tumor Treatment Brain Tumors Overview A brain tumor is a group of abnormal cells that grows in or around the brain. Tumors can directly destroy healthy brain cells. They can
More informationSound in medicine. CH.12. Dr.Rajaa أ.م.د. رجاء سهيل جنم جامعة تكريت كلية طب االسنان. General Properties of Sound
CH.12. Dr.Rajaa Sound in medicine أ.م.د. رجاء سهيل جنم جامعة تكريت كلية Sound : It is the audible waves of frequency between 20 Hz and 20 khz. Infrasound : refers to the sound of frequency below the normal
More informationUltrasound Therapeutics
4 th International Summer School on Emerging Technologies in Biomedicine Brain Molecular Imaging and Molecular Delivery Through the Blood-Brain Barrier Ultrasound Therapeutics Elisa Konofagou, PhD Columbia
More informationLeksell Gamma Knife Icon. Treatment information
Leksell Gamma Knife Icon Treatment information You may be feeling frightened or overwhelmed by your recent diagnosis. It can be confusing trying to process a diagnosis, understand a new and challenging
More informationByung Ihn Choi, M.D. Department of Radiology Seoul National University Hospital
Byung Ihn Choi, M.D. Department of Radiology Seoul National University Hospital CEUS & US Elastography : Contents CEUS Introduction Contrast agents & imaging Clinical application US Video WS Summary US
More informationCerebro-vascular stroke
Cerebro-vascular stroke CT Terminology Hypodense lesion = lesion of lower density than the normal brain tissue Hyperdense lesion = lesion of higher density than normal brain tissue Isodense lesion = lesion
More informationGamma. Knife PERFEXION. care. World-class. The Gamma Knife Program at Washington Hospital
The Gamma Knife Program at Washington Hospital PERFEXION Fast, precise, minimally invasive treatment for neurological conditions. Locally based care by internationally Gamma recognized experts. World-class
More informationAAP ZIKA ECHO (EXTENSION FOR COMMUNITY HEALTHCARE OUTCOMES)
AAP ZIKA ECHO (EXTENSION FOR COMMUNITY HEALTHCARE OUTCOMES) HOUSEKEEPING ITEMS For educational and quality improvement purposes, this ECHO session will be recorded Project ECHO collects participation data
More informationEEG IN FOCAL ENCEPHALOPATHIES: CEREBROVASCULAR DISEASE, NEOPLASMS, AND INFECTIONS
246 Figure 8.7: FIRDA. The patient has a history of nonspecific cognitive decline and multiple small WM changes on imaging. oligodendrocytic tumors of the cerebral hemispheres (11,12). Electroencephalogram
More informationFocused Ultrasound and Cancer Immunotherapy
Focused Ultrasound and Cancer Immunotherapy Overview A number of therapeutic modalities including radiation, radiofrequency and laser-induced heating, cryoablation, and focused ultrasound have been shown
More informationWhat Is an Arteriovenous malformation (AVM)?
American Society of Neuroradiology What Is an Arteriovenous malformation (AVM)? From the Cerebrovascular Imaging and Intervention Committee of the American Heart Association Cardiovascular Council Randall
More informationNuclear Medicine and PET. D. J. McMahon rev cewood
Nuclear Medicine and PET D. J. McMahon 150504 rev cewood 2018-02-15 Key Points Nuclear Medicine and PET: Imaging: Understand how Nuc Med & PET differ from Radiography & CT by the source of radiation. Be
More informationFEP Medical Policy Manual
FEP Medical Policy Manual Effective Date: October 15, 2018 Related Policies: 4.01.11 Occlusion of Uterine Arteries Using Transcatheter Embolization 7.01.95 Radiofrequency Ablation of Miscellaneous Solid
More informationDeep Brain Stimulation: Indications and Ethical Applications
Deep Brain Stimulation Overview Kara D. Beasley, DO, MBe, FACOS Boulder Neurosurgical and Spine Associates (303) 562-1372 Deep Brain Stimulation: Indications and Ethical Applications Instrument of Change
More informationShaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA.
Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA. Shobana Rajan, M.D. Associate staff Anesthesiologist, Cleveland Clinic, Cleveland,
More informationNon-therapeutic and investigational uses of non-invasive brain stimulation
Non-therapeutic and investigational uses of non-invasive brain stimulation Robert Chen, MA, MBBChir, MSc, FRCPC Catherine Manson Chair in Movement Disorders Professor of Medicine (Neurology), University
More informationAblation Lesion Assessment
HRC 2016 Ablation Lesion Assessment The creation of effective and permanent lesions Ian Wright Imperial College Healthcare Wed 09:00-09:30 Hall 11 Objective Examine the role of existing strategies and
More informationContractor Information
PROPOSED/DRAFT Local Coverage Determination (LCD): Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for Essential Tremor (DL37761) Links in PDF documents are not guaranteed to
More informationTMS: Full Board or Expedited?
TMS: Full Board or Expedited? Transcranial Magnetic Stimulation: - Neurostimulation or neuromodulation technique based on the principle of electro-magnetic induction of an electric field in the brain.
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sat, 24 Nov 2018 15:12:21 GMT) CTRI Number Last Modified On 22/10/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationSpecialised Services Policy: CP22. Stereotactic Radiosurgery
Specialised Services Policy: CP22 Document Author: Assistant Director of Planning Executive Lead: Director of Planning ad Performance Approved by: Management Group Issue Date: 01 July 2015 Review Date:
More informationSurgery for Medically Refractory Focal Epilepsy
Surgery for Medically Refractory Focal Epilepsy Seth F Oliveria, MD PhD The Oregon Clinic Neurosurgery Director of Functional Neurosurgery: Providence Brain and Spine Institute Portland, OR Providence
More informationWhat is Ultrasound? What is Ultrasound? B A. Basic Principles of Ultrasound. Basic Principles of Ultrasound. Basic Principles of Ultrasound
Introduction to Ultrasound Principles Mani Montazemi, RDMS Baylor College of Medicine Division of Maternal-Fetal Medicine Department of Obstetrics and Gynecology Manager, Maternal Fetal Center Imaging
More informationDeep Brain Stimulation: Patient selection
Deep Brain Stimulation: Patient selection Halim Fadil, MD Movement Disorders Neurologist Kane Hall Barry Neurology Bedford/Keller, TX 1991: Thalamic (Vim) DBS for tremor Benabid AL, et al. Lancet. 1991;337(8738):403-406.
More informationTania Kaprealian, M.D. Assistant Professor UCLA Department of Radiation Oncology August 22, 2015
Tania Kaprealian, M.D. Assistant Professor UCLA Department of Radiation Oncology August 22, 2015 Most common brain tumor, affecting 8.5-15% of cancer patients. Treatment options: Whole brain radiation
More informationPatient Information. Prostate Tissue Ablation. High Intensity Focused Ultrasound for
High Intensity Focused Ultrasound for Prostate Tissue Ablation Patient Information CAUTION: Federal law restricts this device to sell by or on the order of a physician CONTENT Introduction... 3 The prostate...
More informationCNS TUMORS. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)
CNS TUMORS D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) CNS TUMORS The annual incidence of intracranial tumors of the CNS ISmore than intraspinal tumors May be Primary or Secondary
More informationMolecular Imaging and the Brain
Molecular imaging technologies are playing an important role in neuroimaging, a branch of medical imaging, by providing a window into the living brain. Where CT and conventional MR imaging provide important
More informationNeuro-MS/D Transcranial Magnetic Stimulator
Neuro-MS/D Transcranial Magnetic Stimulator 20 Hz stimulation with 100% intensity Peak magnetic field - up to 4 T High-performance cooling: up to 10 000 pulses during one session Neuro-MS.NET software
More informationTherapy - Minimize harm to patients
Therapy - Minimize harm to patients CHONGQING HAIFU MEDICAL TECHNOLOGY CO., LTD Tel: 86-23-6788 6799/6788 6195/6788 6199 Fax: 86-23-6788 6168 Email: sales@hifu.cn Website: www.haifumedical.com Address:
More informationComputational Medical Imaging Analysis Chapter 7: Biomedical Applications
Computational Medical Imaging Analysis Chapter 7: Biomedical Applications Jun Zhang Laboratory for Computational Medical Imaging & Data Analysis Department of Computer Science University of Kentucky Lexington,
More informationIt s s Always Something!
It s s Always Something! New Approaches in Brain Tumor Treatment Virginia Stark-Vance, M.D. When Something Is a Brain Tumor Brain tumors aren t rare: there are over 100,000/yr Most originate as other cancers
More informationNeuro-MS/D DIAGNOSTICS REHABILITATION TREATMENT STIMULATION. Transcranial Magnetic Stimulator. of motor disorders after the stroke
Neuro-MS/D Transcranial Magnetic Stimulator DIAGNOSTICS of corticospinal pathway pathology REHABILITATION of motor disorders after the stroke TREATMENT of depression and Parkinson s disease STIMULATION
More informationError analysis in neuronavigation
Fakultät für Informatik - Humanoids and Intelligence Systems Lab Institut für Anthropomatik Mittwochs von 12:15-13:45 Error analysis in neuronavigation Uwe Spetzger Neurochirurgische Klinik, Klinikum Karlsruhe
More informationOptimized. clinical pathway. propels high utilization of PET/MR at Pitié-Salpêtrière Hospital
Optimized propels high utilization of PET/MR at Pitié-Salpêtrière Hospital clinical pathway As one of Europe s largest teaching hospitals, Pitié-Salpêtrière Hospital is renowned for its innovative research
More informationMonitoring of Regional Cerebral Blood Flow Using an Implanted Cerebral Thermal Perfusion Probe Archived Medical Policy
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationStroke Imaging Basics. Jeremy Hopkin M.D.
Stroke Imaging Basics Jeremy Hopkin M.D. Goals Introduce the basic physical properties of imaging used in stroke. Understand why each modality is used in the setting of stroke. Understand some strengths
More informationSurgery Within and Around Critical White Matter Tracts
Surgery Within and Around Critical White Matter Tracts Kaisorn L. Chaichana, M.D. Assistant Professor of Neurosurgery, Oncology, and Otolaryngology-Head & Neck Surgery Mayo Clinic Florida, Jacksonville,
More informationOtolaryngologist s Perspective of Stereotactic Radiosurgery
Otolaryngologist s Perspective of Stereotactic Radiosurgery Douglas E. Mattox, M.D. 25 th Alexandria International Combined ORL Conference April 18-20, 2007 Acoustic Neuroma Benign tumor of the schwann
More informationINFORMATION FOR PRESCRIBERS
December 218 EXABLATE MODEL 4 TYPE 1. & TYPE 1.1 APPLICATION: BRAIN ESSENTIAL TREMOR & TREMOR DOMINANT PARKINSON S DISEASE PUB436, Rev 6. 2 CHAPTER # Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter
More informationHigh power density prototype for high precision transcranial therapy
High power density prototype for high precision transcranial therapy M. Pernot a, R. Berriet b, J-F. Aubry a, O. Le Baron b, M. Tanter a, G. Fleury b, L. Chupin b, L. Gallet b, and M. Fink a a Laboratoire
More informationLaser Interstitial Thermal Therapy (LITT) in Neuro-Oncology. Tim Lucas, MD, PhD Neurosurgery
Laser Interstitial Thermal Therapy (LITT) in Neuro-Oncology Tim Lucas, MD, PhD Neurosurgery Timothy.Lucas@uphs.upenn.edu 2016 Laser Interstitial Thermal Therapy (LITT) in Neuro-Oncology Tim Lucas, MD,
More informationPRACTICE GUIDELINE. DEFINITIONS: Mild head injury: Glasgow Coma Scale* (GCS) score Moderate head injury: GCS 9-12 Severe head injury: GCS 3-8
PRACTICE GUIDELINE Effective Date: 9-1-2012 Manual Reference: Deaconess Trauma Services TITLE: TRAUMATIC BRAIN INJURY GUIDELINE OBJECTIVE: To provide practice management guidelines for traumatic brain
More informationFOCAL THERAPY OF PROSTATE CANCER : WHERE ARE WE? MICHAEL MARBERGER PROFESSOR AND CHAIRMAN DEPARTMENT OF UROLOGY MEDICAL UNIVERSITY OF VIENNA
FOCAL THERAPY OF PROSTATE CANCER : WHERE ARE WE? MICHAEL MARBERGER PROFESSOR AND CHAIRMAN DEPARTMENT OF UROLOGY MEDICAL UNIVERSITY OF VIENNA pt2a GL.SC. 6 (3+3) IS TREATMENT OF ENTIRE GLAND NEEDED? MR
More informationApplicable Neuroradiology
For the Clinical Neurology Clerkship LSU Medical School New Orleans Amy W Voigt, MD Clerkship Director Introduction The field of Radiology first developed following the discovery of X-Rays by Wilhelm Roentgen
More informationTechnological advancements improve the sensitivity of CEUS diagnostics
Technological advancements improve the sensitivity of CEUS diagnostics. Martegani, MD, L. iani, MD Department of Diagnostic Imaging, Valduce Hospital, Como, Italy Characterization with Ultrasound B C D
More informationHow we study the brain: a survey of methods used in neuroscience
How we study the brain: a survey of methods used in neuroscience Preparing living neurons for recording Large identifiable neurons in a leech Rohon-Beard neurons in a frog spinal cord Living slice of a
More informationInnovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS
Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis Prof. Ralf R.Kolvenbach MD,PhD,FEBVS Catheter-based thrombolysis Local administration of lytic agent Higher local
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Elias WJ, Huss D, Voss T, et al. A pilot study of focused ultrasound
More informationCNS pathology Third year medical students. Dr Heyam Awad 2018 Lecture 5: disturbed fluid balance and increased intracranial pressure
CNS pathology Third year medical students Dr Heyam Awad 2018 Lecture 5: disturbed fluid balance and increased intracranial pressure ILOs Understand causes and symptoms of increased intracranial pressure.
More informationStress Wave Focusing Transducers
UCRL-K-130697 PREPRINT Stress Wave Focusing Transducers Steven R. Visuri, Richard A. London, Luiz Da Silva This paper was prepared for submittal to Optical Society of America, Spring Topical Meetings Orlando,
More informationNeurosoft TMS. Transcranial Magnetic Stimulator DIAGNOSTICS REHABILITATION TREATMENT STIMULATION. of motor disorders after the stroke
Neurosoft TMS Transcranial Magnetic Stimulator DIAGNOSTICS REHABILITATION TREATMENT of corticospinal pathways pathology of motor disorders after the stroke of depression and Parkinson s disease STIMULATION
More information